Alerts will be sent to your verified email
Verify Email
ZYDUSLIFE
|
Zydus Lifesciences
|
Lupin
|
Dr. Reddy's Labs.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Number of ANDA's Filed in USA
|
508.0 . | 430.0 . | 376.0 . |
|
Number of ANDA's Approved By USFDA
|
435.0 . | 344.0 . | 301.0 . |
|
Domestic Sales Growth - YoY
|
12.0 % | 11.2 % | 11.3 % |
|
US DMF Filings
|
147.0 . | 94.0 . | n/a |
|
R&D as a % of Total Sales
|
9.2 % | 7.5 % | 7.3 % |
|
Financials
|
|||
|
5 yr Average ROE
|
18.47 % | 8.95 % | 15.68 % |
|
5yr average Equity Multiplier
|
1.52 | 1.73 | 1.41 |
|
5yr Average Asset Turnover Ratio
|
0.66 | 0.75 | 0.74 |
|
5yr Avg Net Profit Margin
|
19.02 % | 5.06 % | 15.18 % |
|
Price to Book
|
4.05 | 4.77 | 2.97 |
|
P/E
|
21.8 | 20.08 | 26.85 |
|
5yr Avg Cash Conversion Cycle
|
-84.89 Days | -84.38 Days | 74.48 Days |
|
Inventory Days
|
36.38 Days | 53.29 Days | 76.14 Days |
|
Days Receivable
|
36.93 Days | 50.0 Days | 95.44 Days |
|
Days Payable
|
160.15 Days | 160.27 Days | 102.6 Days |
|
5yr Average Interest Coverage Ratio
|
30.19 | 6.26 | 35.66 |
|
5yr Avg ROCE
|
19.65 % | 10.02 % | 21.82 % |
|
5yr Avg Operating Profit Margin
|
24.4 % | 14.15 % | 23.61 % |
|
5 yr average Debt to Equity
|
0.17 | 0.3 | 0.12 |
|
5yr CAGR Net Profit
|
16.23 % | 21.95 % | 23.71 % |
|
5yr Average Return on Assets
|
12.22 % | 3.91 % | 11.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.0 % | 46.86 % | 26.63 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.02 % | -0.22 % | -0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.71 % | -0.03 % | 3.32 % |
|
Zydus Lifesciences
|
Lupin
|
Dr. Reddy's Labs.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
Therapeutic Area Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|